Welcome to the Psychedelic Spotlight podcast. In this episode, the Psychedelic Investor sits down with Dr. Carol Routledge, Chief Scientific and Chief Medical Officer of Small Pharma (TSX.V: DMT, OTC: DMTTF). Dr. Carol Routhledge is an expert in psychedelic medicines, and she specializes in DMT.
In this interview, we attempted to answer the following questions:
What happens when you take DMT?
Can DMT help with depression?
Is DMT safe?
Small Pharma is a company that I am very excited about, as they are focussing on the psychedelic DMT, which I believe to have unlimited potential as a mental health drug.
Small Pharma is currently running a phase 2 Clinical Trial Attempting to treat Major Depressive Disorder using DMT, the world’s furthest progress DMT Study. We can expect results by the end of the year. If they are successful, the company will begin a phase 3 trial.
Get a roundup of Psychedelic news stories in your inbox
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
Shutterstock 
Psychedelic Business Spotlight — January 14